Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology
Prevalence of hereditary angioedema
12 evidence topics · 9 sources
Prevalence and incidence: systematic literature review
Pooled diagnosed annual prevalence: combined HAE types and 95% confidence interval
Pooled diagnosed annual prevalence by HAE type and by region
United States prevalence of all HAE types: commercial claims database, 2018 to 2020
“No US prevalence for all types of HAE has been estimated.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“For 2018, 2019, and 2020, the claims-based algorithm yielded overall annual unadjusted HAE prevalence estimates per 100,000 and number of people diagnosed with HAE of 2.67, 9559; 2.61, 9341; and 2.43, 8694, respectively.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The corresponding estimates based on expert physician analysis were 2.13, 7602; 2.03, 7275; and 1.84, 6595, respectively.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Our calculations (which exceed the frequently cited 2:100,000 prevalence for HAE with C1 inhibitor deficiency) afford a real-world projected prevalence encompassing all types of HAE.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Worldwide pooled prevalence: systematic review and meta-analysis of 24 studies
“Twenty-four studies from 2000 to 2024 were included in the analysis, describing 11,245 cases of HAE.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The pooled prevalence of HAE was 1.22 cases per 100,000 people (95% confidence interval [CI]: 0.91, 1.53), with lower prevalences reported in Asia and Africa compared to Europe and North America.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“HAE type 1 made up most of the cases, with a slight female predominance.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Prevalence of diagnosed HAE type 1 and 2: Finnish national register
Minimum prevalence of HAE types 1 and 2: United Kingdom survey of 37 centers
“The survey identified 1152 patients with HAE-1/2 (58% female and 92% type 1), 22 patients with HAE with normal C1 inhibitor, and 91 patients with acquired C1 inhibitor deficiency.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Data were provided by 37 centers across the United Kingdom.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“This gives a minimum prevalence of 1:59,000 for HAE-1/2 and 1:734,000 for acquired C1 inhibitor deficiency in the United Kingdom.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Minimal prevalence in the Asia Pacific region: survey of 12 countries and territories
“Completed questionnaires were received from 14 representatives of 12 member countries and territories, representing 46% of the world population.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Overall minimal prevalence of HAE in the AP region was 0.02/100,000 population, with significant heterogeneity across different centers.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Population prevalence of HAE with C1-INH deficiency: South Australia, 2021 to 2022
“Case ascertainment was conducted over 18 months from January 2021 to July 2022, using a range of approaches with the aim of identifying all people with C1INH-HAE in South Australia.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“We identified 35 people with HAE in South Australia, yielding a population prevalence of 1 in 52,400, in line with average established international prevalence.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“There are relatively few systematic population prevalence studies, with reports from various countries of between 1 in 20,000 and 1 in 150,000.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote